FDA Modernization Act 2.0: A step in the right direction
Drug Discovery World
APRIL 12, 2023
Products and technologies such as cell-based assays, microphysiological systems and computer modelling will now all be regarded as suitable alternatives to animal testing in the early phases of drug development. The limitations of animal studies are widely documented.
130 
Let's personalize your content